The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.
2.
When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.
3.
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?
4.
Urinary tract cancer prediction models with high sensitivity and specificity
5.
Mapping lifelong chronic health risks for childhood cancer survivors
1.
Modern Updates in Hematology in the Digital Era
2.
Mechanisms of Tumor Cell Plasticity During Metastatic Spread
3.
Oral Treatment Strategies in Psoriasis & Melasma: Where Are We Heading?
4.
The Science Behind Thrombolytic Drugs and Their Benefits
5.
Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
2.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation